A5005646676- Pulmonary Hypertension Research and Treatments
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Congenital Heart Disease Studies
- Heart Failure Treatment and Management
- Cardiac Imaging and Diagnostics
- Liver Disease and Transplantation
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Vascular Anomalies and Treatments
- Systemic Sclerosis and Related Diseases
- Cardiac Arrhythmias and Treatments
- Cardiovascular Disease and Adiposity
- Healthcare Systems and Public Health
- Venous Thromboembolism Diagnosis and Management
- Renin-Angiotensin System Studies
- Ultrasound in Clinical Applications
- Thermoregulation and physiological responses
- Hormonal Regulation and Hypertension
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiovascular Effects of Exercise
- Nitric Oxide and Endothelin Effects
- Liver Disease Diagnosis and Treatment
- Infrared Thermography in Medicine
National Medical Research Center of Cardiology
2015-2025
Pirogov Russian National Research Medical University
2019-2025
Research Medical Center
2018-2024
Ministry of Health of the Russian Federation
2015-2022
Institute of Experimental Cardiology
2011-2020
National Medical and Surgical Center named after N.I. Pirogov
2019
Institute of Cardiology
2013-2019
Ministry of Health
2015-2017
Pulmonary Hypertension Association
2016
Institute of Clinical Research
2012
.
.
Russian Society of Cardiology (RSC) With the participation: Association Cardiovascular Surgeons Russia, Respiratory Society, Federation Anesthesiologists and Resuscitators, Rheumatologists National Congress Radiation Diagnosticians.
The Russian Society of Cardiology (RSC) With the participation of: Association Cardiovascular Surgeons, Eurasian (EAC), Medical on Arterial Hypertension (RMSAH), Respiratory (RRS), Anesthesiologists and Intensive Care Specialists, Radiologists (RSRR), Rheumatologists Russia. Endorsed by Research Practical Council Ministry Health Federation (12.09.2024).
Disclaimer The EAC Guidelines represent the views of EAC, and were produced after careful consideration scientific medical knowledge, evidence available at time their publication. is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies. Health professionals are encouraged take fully into account when...
Assess the prevalence, clinical course, current therapy, and mortality in patients with pulmonary arterial hypertension (PAH) National Registry.In prospective study we included over 18 years of age diagnosed PAH [idiopathic (IPAH); Drug- Toxin-Induced Pulmonary Hypertension; inherited PAH; associated congenital heart disease (PAH-CHD); systemic connective tissue (PAH-CTD); HIV infection (PAH-HIV); portal (portoPAH)]. The observation was carried out 15 expert centers Russia from 01.01.2012 to...
Portal hypertension is a complex syndrome that effects the systemic circulation. Some authors name pulmonary with portal such as portopulmonary hypertension. According to foreign registries, prognosis of patients one most unfavorable. Ultrasound diagnostic methods are ones keis confirm hypertension, while echocardiography detects high pressure in artery, liver ultrasound vascular doppler reveals changes portocaval blood flow. Aim. To analyze clinical, functional and hemodynamic status...
Chronic thromboembolic pulmonary hypertension (CTEPH) is precapillary hypertension, in which chronic obstruction of large and middle branches arteries (PAs) secondary changes the lung microcirculatory bed result a progressive increase vascular resistance PA pressure with development severe right cardiac dysfunction heart failure. CTEPH unique form since it potentially curable by surgical treatment. The diagnostic criteria for are mean ≥25 mm Hg, as evidenced catheterization; wedge ≤15 Hg;...
To study demographic and clinical characteristics to give a comparative description of the functional hemodynamic status, profile concomitant pathology in patients with various forms pulmonary arterial hypertension (PAH), chronic thromboembolic (CTEPH) according Russian National Registry.During period from January 01, 2012, till 2019, 1105 aged >18 years verified diagnosis PAH CTEPH, who were subsequently observed at 15 PH expert centers Federation 52 provinces, are included registry on...
For a long time, the only method of revascularization in patients with chronic thromboembolic pulmonary hypertension (CTEPH) was thromboendarterectomy from branches artery. Transluminal balloon angioplasty (BPA), as an alternative treatment option for inoperable and residual CTEPH, appeared recently, but has already firmly taken its place algorithm significantly improved prognosis such patients. Active use BPA everyday practice served reason creation this consensus order to summarize...
The use of simple functional tests can increase the electrocardiogram sensitivity for detecting pulmonary hypertension (PH). aim work is to evaluate changes in electrical axis heart (EAH) during inhalation patients with proven chronic thromboembolic PH (CTEPH) or suspected CTEPH, referred right catheterization (RHC). Materials and methods. study included 80 who underwent RHC according clinical indications: 25 men 55 women aged 52 ± 13 years. EAH was assessed when recording quiet breathing on...
On December 13, 2024, the final working group meeting was held, purpose of which to discuss common position experts on problem chronic thromboembolic pulmonary hypertension various specialties: cardiologists, cardiac surgeons, pulmonologists, issues assessing operability patients, risk stratification and choice therapy in patients with inoperable residual forms pathology. The discussion field included a wide range that often arise real clinical practice, but specific answers them are not...
Disclaimer. The EAC Guidelines represent the views of EAC, and were produced after careful consideration scientific medical knowledge, evidence available at time their publication. is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies. Health professionals are encouraged take fully into account when...
To evaluate the influence of riociguat on World Health Organization functional class (WHO FC), 6-min walk distance (6MWD), right heart remodeling, and ventricular–pulmonary arterial (RV–PA) coupling in patients with idiopathic pulmonary hypertension (IPAH) who are treatment-naïve or have failed to achieve treatment goals sildenafil therapy. Twenty IPAH were enrolled: 12 had not previously received PAH-targeted therapy (treatment-naïve subgroup) 8 been receiving but goals; entering this pilot...
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) in countries limited resources have, to date, been poorly represented registries.
Introduction. A deep breath causes a whole range of physiological effects that are reflected in the electrocardiogram. The purpose study is to assess position electrical axis heart during inspiration compared quiet breathing patients with precapillary pulmonary hypertension and compare these data echocardiographic characteristics structural functional state heart. Materials methods. included 40 idiopathic chronic thromboembolic hypertension. Echocardiography assessed size chambers, systolic...
Objective. The aim of the study is to examine treatment patterns, hospitalizations, work disability and describe demographic clinical characteristics newly diagnosed patients with pulmonary arterial hypertension (PAH) before after diagnosis verification in real practice Russia. Design methods. Longitudinal prospective observational a retrospective part was conducted. Adult were included PAH based on right heart catheterization. data received via interviewing medical documentation analysis at...
The paper gives current approaches to treating chronic thromboembolic pulmonary hypertension (CTEPH) from the document «Federal Guidelines for Diagnosis and Treatment of CTEPH» approved at Third Russian Congress on Pulmonary Hypertension December 11, 2015. guidelines had been elaborated optimize treatment patients with CTEPH basis an analysis data present-day registries multicenter randomized clinical trials, national international consensus documents, documents published in recent years. is...